• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Montelukast as Monotherapy for Pediatric Asthma.

作者信息

Gaffin Jonathan M, Phipatanakul Wanda

机构信息

The Department of Medicine, Division of Pulmonology, Children's Hospital, Boston, Boston, Massachusetts ; Harvard Medical School, Boston, Massachusetts.

出版信息

MP Med Prakt Pediatr. 2009;3(63):20-23.

PMID:24009473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3760433/
Abstract
摘要

相似文献

1
Montelukast as Monotherapy for Pediatric Asthma.孟鲁司特作为儿童哮喘的单一疗法
MP Med Prakt Pediatr. 2009;3(63):20-23.
2
Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study.孟鲁司特单药或联合吸入性皮质类固醇治疗未控制哮喘的儿科患者的疗效：一项前瞻性队列研究。
Allergy Asthma Clin Immunol. 2014 May 6;10(1):21. doi: 10.1186/1710-1492-10-21. eCollection 2014.
3
Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma.持续性哮喘患儿对口服孟鲁司特和吸入性氟替卡松的依从性。
Pharmacotherapy. 2001 Dec;21(12):1464-7. doi: 10.1592/phco.21.20.1464.34485.
4
Review of recent results of montelukast use as a monotherapy in children with mild asthma.孟鲁司特作为单一疗法用于轻度哮喘儿童的近期结果综述。
Clin Ther. 2008;30 Spec No:1026-35. doi: 10.1016/j.clinthera.2008.05.018.
5
Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review.孟鲁司特作为吸入性糖皮质激素的附加疗法用于治疗轻至中度哮喘：一项系统评价
Thorax. 2008 May;63(5):453-62. doi: 10.1136/thx.2007.081596.
6
Montelukast in pediatric asthma management.孟鲁司特在儿童哮喘管理中的应用
Indian J Pediatr. 2006 Apr;73(4):275-82. doi: 10.1007/BF02825818.
7
Montelukast in general pediatric practices.孟鲁司特在普通儿科实践中的应用
J Med Assoc Thai. 2005 Sep;88 Suppl 4:S348-51.
8
Treatment of pediatric mild persistent asthma with low-dose budesonide inhalation suspension vs. montelukast in China.在中国，用低剂量布地奈德混悬液吸入疗法治疗小儿轻度持续性哮喘与孟鲁司特钠的对比。
World J Pediatr. 2021 Dec;17(6):619-625. doi: 10.1007/s12519-021-00464-7. Epub 2021 Oct 6.
9
Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?吸入性糖皮质激素或孟鲁司特作为儿童哮喘首选的长期主要治疗药物？
Eur J Pediatr. 2008 Jul;167(7):731-6. doi: 10.1007/s00431-007-0644-3. Epub 2008 Jan 24.
10
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.三种控制方案用于轻度至中度持续性儿童哮喘的长期比较：儿童哮喘控制试验
J Allergy Clin Immunol. 2007 Jan;119(1):64-72. doi: 10.1016/j.jaci.2006.09.042. Epub 2006 Nov 30.

本文引用的文献

1
Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children.孟鲁司特治疗儿童呼吸道合胞病毒毛细支气管炎后呼吸症状的研究。
Am J Respir Crit Care Med. 2008 Oct 15;178(8):854-60. doi: 10.1164/rccm.200706-910OC. Epub 2008 Jun 26.
2
Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?吸入性糖皮质激素或孟鲁司特作为儿童哮喘首选的长期主要治疗药物？
Eur J Pediatr. 2008 Jul;167(7):731-6. doi: 10.1007/s00431-007-0644-3. Epub 2008 Jan 24.
3
Global strategy for asthma management and prevention: GINA executive summary.哮喘管理和预防全球战略：全球哮喘防治创议执行摘要
Eur Respir J. 2008 Jan;31(1):143-78. doi: 10.1183/09031936.00138707.
4
Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report.儿童哮喘的诊断与治疗：PRACTALL共识报告
Allergy. 2008 Jan;63(1):5-34. doi: 10.1111/j.1398-9995.2007.01586.x.
5
Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.布地奈德吸入混悬液与孟鲁司特治疗轻度持续性哮喘幼儿的对比研究
J Allergy Clin Immunol. 2007 Nov;120(5):1043-50. doi: 10.1016/j.jaci.2007.08.063.
6
Randomized comparison of strategies for reducing treatment in mild persistent asthma.轻度持续性哮喘治疗减量策略的随机对照比较
N Engl J Med. 2007 May 17;356(20):2027-39. doi: 10.1056/NEJMoa070013.
7
Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast.5-脂氧合酶生物合成途径的药物遗传学及孟鲁司特的临床反应差异
Pharmacogenet Genomics. 2007 Mar;17(3):189-96. doi: 10.1097/FPC.0b013e3280120043.
8
Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma.哮喘患者尿半胱氨酰白三烯E4水平与抗白三烯治疗临床反应的关系。
Lung. 2007 Mar-Apr;185(2):105-12. doi: 10.1007/s00408-006-0001-8. Epub 2007 Mar 28.
9
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.三种控制方案用于轻度至中度持续性儿童哮喘的长期比较：儿童哮喘控制试验
J Allergy Clin Immunol. 2007 Jan;119(1):64-72. doi: 10.1016/j.jaci.2006.09.042. Epub 2006 Nov 30.
10
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.轻度至中度持续性儿童哮喘患者对氟替卡松和孟鲁司特的反应情况
J Allergy Clin Immunol. 2006 Jan;117(1):45-52. doi: 10.1016/j.jaci.2005.10.012.